Safe Group Announces Strategic Agreements with Wenzel Spine
03 Octobre 2022 - 05:46PM
Safe Group Announces Strategic Agreements with Wenzel Spine
- Distribution agreement in USA between Wenzel Spine and Safe
Orthopaedics
- Manufacturing agreement between Wenzel Spine and Safe
Medical
Eragny-sur-Oise, France, October 3rd,
2022, 17h45 CET – Safe (FR0013467123 – ALSAF), a
company specializing in the design, manufacturing, and marketing of
single-use technologies for spinal surgeries, announces the
signature of a distribution agreement of Safe Orthopaedics products
in the USA by Wenzel Spine and a manufacturing agreement between
Wenzel Spine and Safe Medical. The companies have also initiated
strategic discussions to maximize business synergies.
Wenzel Spine is a medical technology and
services company focused on providing minimally invasive surgical
and diagnostic solutions for the treatment of spinal disorders such
as the S-LIF Procedure using VariLift®-LX and S-ACDF using
VariLift®-C. These stand-alone lumbar and cervical fusion
procedures are true MIS alternatives to a more traditional approach
to spine fusion, which necessitate the use of supplemental fixation
such as rods, screws, or plates. VariLift-LX is the only
FDA-cleared posterior stand-alone lumbar interbody fusion device on
the market that requires significantly less hardware to promote
fusion while prioritizing healthy anatomy preservation. For the
right patient, these procedures may be an ideal solution for
hospital outpatient and Ambulatory Surgery Center (ASCs)
environments.
Wenzel Spine’s solutions have been used by over
300 surgeons in 39 states across the USA. With access to over 2,000
hospitals and ASCs and supported by a strong distribution network,
Wenzel Spine has seen outpatient revenue climb 196% post-COVID.
With a shared vision to bring more unique
treatment options to surgeons and their patients, Wenzel Spine and
Safe Orthopaedics will immediately begin distributing the Safe
Orthopaedics ready-to-use technologies (MIS pedicle screws and
vertebral augmentation technologies) and Wenzel Spine implants
throughout the USA.
In parallel, Safe Medical will support the
design of ready-to-use technologies and manufacturing of Wenzel
Spine products. The products will be produced in the CIPI* in
Fleurieux-sur-l’Arbresle offering machining, finishing, and
packaging industrial services.
Wenzel Spine and Safe Group have also initiated
strategic discussions to maximize business synergies:
- Wenzel Spine’s diagnostic and surgical planning technology
solutions allow for the combined evaluation of Safe Group’s SORA
technology which offers surgery online assistance, assisted
selection of implants and instruments, and automatic replenishment.
The combination of these technologies provides the opportunity to
offer a ‘next-practice’ surgical platform to surgeons,
distributors, and facilities.
- Wenzel Spine technologies are currently only available in the
USA. Optimizing the cost of technologies with Safe Medical and
developing ready-to-use instrument sets for Wenzel Spine’s implants
will help to initiate distribution throughout Europe.
“We are excited about the opportunity to partner
with Safe Group on multiple fronts as we look to expand Wenzel
Spine’s reach within the ASC, outpatient, and acute care markets in
the USA and abroad.” said William Wilson, Co-Founder and CEO of
Wenzel Spine. “As we continue to accelerate our growth, especially
in the outpatient fusion market, Safe’s ready-to-use solutions and
applications with Wenzel’s products will increase the value of our
technology and service offerings to our clients and most
importantly their patients.”
Pierre Dumouchel, Co-Founder, Chairman and CEO
of Safe Group, adds “I’m pleased to announce our new partnership
with Wenzel Spine. The alignment of our vision and technologies
will allow our US sales teams to offer unique solutions to our
clients for better treatment of their patients, especially in the
rapidly growing ambulatory or outpatient environment. Starting with
distribution and manufacturing agreements, we expect to accelerate
our short-term sales growth and financial performance. We will
continue to analyze mid-term options to maximize synergies between
Wenzel and Safe.”
Financial Agenda:Q4 sales and
S1 financial results on Wednesday October 5th.
About Wenzel Spine, Inc.Wenzel
Spine, Inc. is a medical technology and services company focused on
providing minimally invasive solutions for the treatment of spinal
disorders. Headquartered in Austin, TX, Wenzel Spine is focused on
delivering surgical solutions that improve the overall quality of
spine care by simplifying procedures and reducing recovery time.
Wenzel Spine seeks to improve patient quality of life by designing
and producing devices of the highest quality to support our surgeon
clients in the care and treatment of their patients.
For more information about the company and
products, visit www.wenzelspine.com.
About Safe GroupSafe Group is a
French medical technology group that brings together Safe
Orthopaedics, a pioneer in ready-to-use technologies for spine
pathologies, and Safe Medical (formerly LCI Medical), a medical
device subcontractor for orthopaedic surgery. The group employs
approximately 150 people.
Safe Orthopaedics develops and manufactures kits
combining sterile implants and single-use instruments, available at
any time to the surgeon. These technologies are part of a minimally
invasive approach aimed at reducing the risks of contamination and
infection, in the interest of the patient and with a positive
impact on hospitalization times and costs. Protected by 18 patent
families, SteriSpineTM kits are CE marked and FDA approved. Safe
Orthopaedics is headquartered in the Paris region (95610
Eragny-sur-Oise) and has subsidiaries in the United Kingdom,
Germany, the United States, and the Lyon region
(Fleurieux-sur-l'Arbresle).
For more information:
http://www.safeorthopaedics.com/
Safe Medical produces implantable medical
devices and ready-to-use instruments. It has an innovation center
and two production sites in France (Fleurieux-sur-l'Arbresle,
69210) and in Tunisia, offering numerous industrial services:
design, industrialization, machining, finishing and sterile
packaging. Supported by the French stimulus plan in 2020, the
company invests in additive printing and will be operational in
2022 on this new technology.
For more information:
http://www.safemedical.fr/
Contacts
Wenzel SpineWilliam Wilson
Chief Executive Officer 512-469-6066 info@wenzelspine.com
Safe
Group
François-Henri Reynaud
Chief Financial and Administrative Officer
Tél. : +33 (0)1 34 21 50
00
investors@safeorthopaedics.com
- 20221003_PR-WenzelSafe vDef
SAFE (EU:ALSAF)
Graphique Historique de l'Action
De Fév 2024 à Mar 2024
SAFE (EU:ALSAF)
Graphique Historique de l'Action
De Mar 2023 à Mar 2024